The Endonucleases market is witnessing increased adoption in synthetic biology. Researchers use DNA-cleaving enzymes to construct, modify, and assemble genetic components for engineered biological systems.
The endonucleases market size is expected to reach US$ 892.51 million by 2034 from US$ 395.07 million in 2025, registering a CAGR of 9.48% during 2026–2034. Endonucleases are enzymes...
